LRRK2 and Parkinson disease: We used an enriched cohort of GBA and LRRK2 PD patients and non-manifesting carriers in order to determine the association between the metabolic syndrome and its’ components with PD phenotype and study the influence of the metabolic syndrome on the prevalence of prodromal features of PD among individuals at risk for future disease.